Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
Trial details
- Registry ID
- NCT05320393
- Phase
- Phase 2
The FDA approved OnabotulinumtoxinA (Botox Cosmetic) on 9 Dec 1991.
Drug identity checked against registry records
Also recorded as Botox Cosmetic
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar LinesNCT05320393 | EOLS | Phase 2 | Completed | 2023-05-22Actual |
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 1991-12-09Day | OnabotulinumtoxinA | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA103000", "applicant_as_listed_by_fda": "ALLERGAN", "brand_names": ["BOTOX", "BOTOX COSMETIC"], "active_ingredients": ["OnabotulinumtoxinA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19911209", "matched_on": "drug name equals FDA sole active ingredient"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |